Konrad Bleicher holds a Ph.D. in Organic Chemistry, which he received from the Tübingen University in Germany. He started his professional career at Sandoz/Novartis (Switzerland & US) where he gained experience in the area of Combinatorial Chemistry before joining Roche as a scientist in the CNS chemistry department. Since then he has been holding various positions in the Small Molecule Medicinal Chemistry area (Hit ID, Lead ID & Lead Optimization). In 2009 Dr. Bleicher was nominated “Peptide Area Head”, overseeing the peptide chemistry activities in Pharma Research & Early Development. Since 2016 he is responsible for the RNA Therapeutics Chemistry strategy and platform development in Roche Basel. He is the author of over 80 patents/publications and an invited speaker for various international conferences.